How Much is Health Spending Expected to Grow? - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

What Growth Is Projected for U.S. Health Spending?

  • By

  • Shameek Rakshit

  • Imani Telesford

  • Aubrey Winger

  • Lynne Cotter

  • Juliette Cubanski

  • Matt McGough

  • October 22, 2026

Share

Clinical Scorecard: What Growth Is Projected for U.S. Health Spending?

At a Glance

CategoryDetail
ConditionU.S. national health spending projections
Key MechanismsPolicy modifications and shifts in health care utilization are projected to moderate spending growth, including Medicaid changes enacted through the 2025 budget reconciliation law and expiration of enhanced ACA Marketplace premium tax credits in 2025. Over the longer term, Medicare prescription drug provisions and inflation rebates are expected to reduce Medicare prescription drug spending growth.
Target PopulationU.S. national health spending
Care SettingNational health expenditure projections

Key Highlights

  • Health spending is projected to reach $6.0 trillion in 2026, or 18.7% of the economy.
  • Hospitals are projected to account for the largest share of spending in 2026, at $1.9 trillion.
  • Spending is projected to rise to $9.0 trillion by 2034, representing more than one-fifth of the U.S. economy.
  • Annual spending growth is projected at 6.3% in 2026 and 4.7% in 2027.
  • Policy changes and shifts in utilization are projected to moderate spending growth. Over the longer term, the Inflation Reduction Act’s Medicare prescription drug provisions and inflation rebates are expected to reduce Medicare prescription drug spending growth, despite faster projected Medicare spending growth in the near term.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • The Peterson-KFF Health System Tracker is an information hub for this analysis.

      Risks

        Patient & Prescribing Data

        No patient-level treatment or prescribing guidance is provided. The source says the Inflation Reduction Act’s Medicare prescription drug provisions and inflation rebates are expected to reduce Medicare prescription drug spending growth over the longer term, despite faster projected Medicare spending growth in the near term.

        Clinical Best Practices

          Related Resources & Content

            Original Source(s)

            Related Content